Chemical inhibitors of FAM26A can function by targeting various ion channels that the protein may regulate, leading to functional inhibition through several distinct molecular mechanisms. Tetrodotoxin and Conotoxin are two such inhibitors that act by blocking voltage-gated sodium channels. This blockade prevents sodium ions from entering the cell, which is critical for the generation and propagation of electrical signals. Since FAM26A is associated with ion transport regulation, the inhibition of these channels by Tetrodotoxin and Conotoxin directly impedes the ion fluxes under the control of FAM26A. Similarly, Omega-Agatoxin, ω-Conotoxin GVIA, SNX-482, and Ziconotide target different types of voltage-gated calcium channels, crucial for calcium ion homeostasis and signaling. By inhibiting these channels, these toxins disrupt the pathways that FAM26A may modulate, thereby inhibiting the protein's function in regulating calcium ion flow.
Additionally, Ryanodine and Thapsigargin inhibit calcium signaling by binding to ryanodine receptors and inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) respectively. Ryanodine's action on ryanodine receptors compromises the release of calcium from intracellular stores, while Thapsigargin's effect on SERCA disrupts calcium reuptake into those stores, both of which are critical processes potentially regulated by FAM26A. 2-APB interferes with calcium levels by blocking inositol 1,4,5-trisphosphate receptors and store-operated calcium entry, altering the intracellular environment and inhibiting FAM26A's regulatory function. Verapamil, Nifedipine, and Diltiazem, all calcium channel blockers, further inhibit the influx of calcium ions through L-type calcium channels. This reduction in calcium ion entry is another pathway through which FAM26A's activity can be inhibited, as the proper functioning of these channels may be necessary for the protein to regulate calcium-dependent cellular processes. Each chemical, by disrupting the precise ion channel it targets, can hinder the functional capacity of FAM26A in maintaining ion homeostasis and signaling within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $454.00 | ||
Omega-Agatoxin targets voltage-gated calcium channels (Cav). By inhibiting Cav channels, this toxin would disrupt calcium ion homeostasis and signaling pathways that FAM26A may modulate, functionally inhibiting the protein's capacity to regulate these ions. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Ryanodine binds to the ryanodine receptors which are calcium release channels on the sarcoplasmic and endoplasmic reticulum. Inhibition of these channels can disrupt calcium signaling pathways potentially regulated by FAM26A, leading to its functional inhibition. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). By disrupting the SERCA pump, thapsigargin impairs calcium homeostasis, which could inhibit FAM26A activity related to calcium signaling. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB is known to block inositol 1,4,5-trisphosphate receptors (IP3R) and store-operated calcium entry (SOCE). This inhibition can alter intracellular calcium levels, affecting the cellular environment that FAM26A is involved in, leading to functional inhibition of the protein. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil is a calcium channel blocker that would inhibit the influx of calcium ions through the L-type calcium channels. This inhibition could reduce calcium-dependent processes that are potentially regulated by FAM26A, resulting in functional inhibition. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine is another calcium channel blocker that specifically inhibits L-type calcium channels. It would decrease calcium ion influx and could thereby functionally inhibit FAM26A if the protein is involved in the regulation of these channels. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem selectively inhibits L-type calcium channels. By limiting calcium ion entry, it could impact calcium-dependent signaling pathways where FAM26A plays a regulatory role, leading to functional inhibition of the protein. | ||||||